Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Combination Products Get Extra Year for Postmarket Safety Compliance

  • Post author:Sam
  • Post published:May 3, 2019
  • Post category:The GMP Letter

The FDA gave sponsors of combination drug/device products another year to get their IT affairs in order before complying with new postmarket safety reporting requirements. Source: The GMP Letter

Continue ReadingCombination Products Get Extra Year for Postmarket Safety Compliance

FDA Issues Final Guidance on Bench Performance Testing

  • Post author:Sam
  • Post published:May 3, 2019
  • Post category:The GMP Letter

The FDA issued final guidance recommending what information devicemakers should include in test report summaries, test protocols and complete rest reports for non-clinical bench performance testing for their premarket submissions.…

Continue ReadingFDA Issues Final Guidance on Bench Performance Testing

CDRH Flags Ongoing Concerns Over Contaminated Duodenoscopes

  • Post author:Sam
  • Post published:May 3, 2019
  • Post category:The GMP Letter

CDRH Director Jeff Shuren said the center is considering regulatory actions because of ongoing concerns over contaminated duodenoscopes. Source: The GMP Letter

Continue ReadingCDRH Flags Ongoing Concerns Over Contaminated Duodenoscopes

483 Roundup: FDA Flags Three Firms for Quality, Other Issues

  • Post author:Sam
  • Post published:May 3, 2019
  • Post category:The GMP Letter

The FDA cited three devicemakers for nonconforming products, documentation failures, inadequate CAPAs and numerous other problems found during agency inspections. Source: The GMP Letter

Continue Reading483 Roundup: FDA Flags Three Firms for Quality, Other Issues

FDA Addresses Safety Concerns for Surgical Staplers and Staples

  • Post author:Sam
  • Post published:May 3, 2019
  • Post category:The GMP Letter

The FDA issued a draft guidance and proposed order designed to ensure the safe and effective use of surgical staplers and staples for internal use. Source: The GMP Letter

Continue ReadingFDA Addresses Safety Concerns for Surgical Staplers and Staples

European Commission Releases Details on Eudamed, Nomenclature System

  • Post author:Sam
  • Post published:May 3, 2019
  • Post category:The GMP Letter

The European Commission released long-awaited guidance on Eudamed (the European Database on Medical Devices) and the device nomenclature system that will be used for the EU’s new medical device and…

Continue ReadingEuropean Commission Releases Details on Eudamed, Nomenclature System

Australia Proposes New Device Classifications to Align With EU Regs

  • Post author:Sam
  • Post published:April 5, 2019
  • Post category:The GMP Letter

Australia’s TGA released five new draft guidances that propose changes to the classification of numerous medical devices to align more closely with European Union regulations. Source: The GMP Letter

Continue ReadingAustralia Proposes New Device Classifications to Align With EU Regs

CDRH Warns of Device Shortages Following Sterilizer’s Suspension

  • Post author:Sam
  • Post published:April 5, 2019
  • Post category:The GMP Letter

CDRH warned that more than 100 device manufacturers and hundreds of devices face potential shortages following an EPA order to stop medical equipment sterilizer Sterigenics’ Willbrook, Illinois facility from sterilizing…

Continue ReadingCDRH Warns of Device Shortages Following Sterilizer’s Suspension

EC Issues Guidance on Eudamed, Nomenclature System

  • Post author:Sam
  • Post published:April 5, 2019
  • Post category:The GMP Letter

The European Commission released long-awaited guidance on Eudamed (the European Database on Medical Devices) and the device nomenclature system that will be used for the EU’s new medical device and…

Continue ReadingEC Issues Guidance on Eudamed, Nomenclature System

FDA Lays Out New Guidance on Anthrax Testing Devices

  • Post author:Sam
  • Post published:April 5, 2019
  • Post category:The GMP Letter

The FDA released new guidance for devicemakers hoping to sell equipment to test for anthrax and other dangerous bacteria. Source: The GMP Letter

Continue ReadingFDA Lays Out New Guidance on Anthrax Testing Devices
  • Go to the previous page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.